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Abstract
Hispanic individuals are at greater risk for health disparities, less than optimal health care, and are 
diagnosed at later stages of cognitive impairment than white non-Hispanics. Acculturation and 
different attitudes toward test-taking may result in decrements in performance, especially on 
unfamiliar measures that emphasize speed and accuracy. Non-Hispanic individuals often 
outperform Hispanic individuals on cognitive and neuropsychological measures in community and 
clinical populations. Current neuropsychological testing may not provide accurate data related to 
monolingual and bilingual individuals of Hispanic descent. Testing instruments were identified by 
searching academic databases using combinations of relevant search terms. Neuropsychological 
instruments were included if they were designed to detect cognitive impairment, had an 
administration time of less than 45 minutes, and were available in English. Validity studies were 
required to employ gold standard comparison diagnostic criteria. Twenty-nine instruments were 
evaluated in dementia staging, global cognition, memory, memory and visual abilities, working 
memory and attention, verbal learning and memory, recall, language, premorbid intelligence, 
literacy/cognitive reserve, visuospatial, attention, problem-solving, problem solving and 
perception, functional assessment, and mood/daily functioning domains. Spanish-language 
neuropsychological instruments need to be made widely available and existing instruments to be 
normed in Spanish to best serve and assess diverse populations. Psychometric data were reported 
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for neuropsychological instruments, which may be administered to Hispanic older adults 
presenting for evaluation related to dementia-spectrum disorders. This is one of the few reviews to 
provide an overview of the sensitivity and specificity of available Spanish translated 
neuropsychological instruments.
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Hispanic individuals are at greater risk for health disparities and less than optimal health and 
mental health care (Langellier, Chen, Vargas-Bustamante, Inkelas, & Ortega, 2016; Vega, 
Rodriguez, & Gruskin, 2009). Individuals from these population groups require even greater 
diligence from health care providers to detect cognitive impairment or conditions such as 
delirium, which may be mistakenly diagnosed as mild cognitive impairment (MCI) or 
dementia (Siddiqi, House, & Holmes, 2006). The disparities known to exist in the 
recognition and diagnosis of dementia in Hispanics, support the concern that a delirium state 
will be under recognized and improperly diagnosed. Studies have indicated that similar to 
other ethnic minorities, Hispanics are diagnosed at later stages of cognitive impairment than 
white non-Hispanics (Chin, Negash, & Hamilton, 2011). Hispanics may experience higher 
risk factors that are associated with cognitive impairment and AD development, such as 
diabetes, cardiovascular risk factors (Evans et al., 1997; Haan et al., 2003; Lopez et al, 
2003), and vascular disease, (O’Bryant et al., 2007, 2013; Tang et al., 2001), which may be 
mistaken for AD itself or cause delirium symptoms. Moreover, some evidence suggests that 
Hispanics present with higher levels of depressive symptoms and cognitive impairment than 
white non-Hispanics, which may contribute to the higher prevalence of AD diagnosis (Bell-
McGinty et al., 2002; Livney et al., 2011), in people with and, most concerning, without AD 
pathology.
Individual cultural attitudes may affect neuropsychological, and to a lesser extent, functional 
test scores (Ostrosky-Solis, Ramirez, & Ardila, 2004; Rosselli et al., 2002; Sayegh & 
Knight, 2013; Tappen, Rosselli, & Engstrom, 2010). Cultural factors include differences 
how one might consider of the facilitators request to interpret and respond to a given task 
with the utmost speed, rigor, and precision (Ardila, 2013; Green, Rohling, Lees-Haley, & 
Allen, 2001). Acculturation level (Arnold, Montgomery, Castañeda, & Longoria, 1994; 
Razani, Burciaga, Madore, & Wong, 2007) and attitudes may influence test taking. Which 
may result in poorer performance It is established that effort can account for more variance 
than cognitive impairment (Green et al., 2001), and significant differences in testing 
outcomes can be accounted for by differences in levels of motivation (Liu, Bridgeman, & 
Adler, 2012). As such, effort and motivation remain crucial concepts to explore when 
considering differing approaches to test-taking. For instance, the requirement for providing 
optimal performance for a task may be deemphasized in certain cultures. This issue arises in 
all levels of testing, including high-stakes testing related to academic performance and 
college entrance exams. In one paper, Altshuler and Schmautz (2006) found that certain 
cultural values that are emphasized in Hispanic culture may, at times, appear to influence 
maximal performance. These values include interdependence over autonomy, and an 













allocentric self-concept as opposed to an idiocentric self-concept. As such, white non-
Hispanic participants may have an advantage increasing performance on neuropsychological 
tests developed and delivered in English with instructions placing importance on autonomy 
and independence.
Current neuropsychological testing, utilizing traditional assessment instruments, may not be 
sufficient in providing accurate data related to disease diagnosis and progression in bilingual 
participants. In cross-cultural studies, the use of neuropsychological test scores, as an index 
of the severity of underlying disease process in the brain (even when using validly translated 
and back-translated tests), may be subject to nuances of language. One recent study found 
that while traditional neuropsychological instruments demonstrated linear patterns of decline 
in monolingual participants, a quadratic decline was found for bilingual individuals 
(Anderson, Saleemi, & Bialystok, 2017). This same study raised the question of whether 
classification errors may occur as a result of utilizing standard neuropsychological tests with 
bilingual participants. Previous studies have found that non-Hispanic individuals outperform 
Hispanic individuals in the dementia and clinical populations among cognitive screeners and 
other neuropsychological measures (Boone, Victor, Wen, Razani, & Pontón, 2007; Gross et 
al., 2015; Mungas, Reed, Farias, & DeCarli, 2009; Razani, Burciaga, et al., 2007; Razani, 
Murcia, Tabares, & Wong, 2007), even though, in some cases, volumes of brain regions 
among Hispanic individuals indicated less atrophy than White non-Hispanic participants in 
the same study Burke et al., 2018. The purpose of this study is to review prominent validated 
neuropsychological assessments within the published literature to determine efficacy for 
implementation with diverse English and Spanish speaking populations based on gold 
standard diagnostic criteria.
Methods
Neuropsychological instruments were identified by searching electronic databases (Entrez-
PubMed, CINAHL, PsycINFO, EBSCOhost, and Google Scholar), using combinations of 
the following terms: “dementia,” “Alzheimer’s disease,” “cognitive impairment,” 
“screening,” “English,” “Spanish,” “sensitivity,” and “specificity.” Individual test names 
were also used as search terms. In addition, the reference lists of papers located in the 
original search were then manually explored. We did not evaluate global mental status tests, 
such as the mini-mental status exam (MMSE) and the Montreal Cognitive Assessment 
(MOCA) because there have been a number of reviews on cognitive screeners. 
Neuropsychological measures were included if they were employed in the assessment of 
cognitive impairment or had been used for that purpose, had an administration time of less 
than 45 minutes and were available in English. These instruments could be administered 
directly to patients, or be partially or fully informant informant-rated. Individual papers 
relating instrument information were included if they: were the original paper presenting the 
content of the test; presented data relating to the screening aspects of the instrument (as 
opposed to aspects such as factor structure, which are outside the scope of the current 
paper); presented data relating to the performance of the test as it stands alone (i.e., validity 
statistics based on scores from combined sources [screen test plus functional status, for 
example] were not considered).













Validity studies must also have employed acceptable “gold standard” diagnostic criteria (i.e., 
based on international diagnostic guidelines or clinical judgment following a full assessment 
battery); the use of another screening test as the gold standard was not acceptable. Where 
denoted, the test sensitivity is the ability of a test to correctly identify those with the disease 
(true positive rate). Test specificity is the ability of the test to correctly identify those without 
the disease (true negative rate). Parikh and colleagues (2008) provide an excellent overview 
of sensitivity, specificity, and positive and negative predictive values. It should be noted that 
sensitivity and specificity applies to the aspects of a test while actual positive and negative 
values are dependent on the percentage of true positive and true negative cases in a 
population.
Data were extracted for each screen by one author. A list of cognitive, psychiatric, and 
functional domains/abilities assessed by each test was created independently by two of the 
authors, and a final list was agreed upon by consensus, with a third author consulted as 
necessary. Neuropsychological tests were organized by classifications according to the 
domain structure set forth by McKhann et al. (2011). These domains included: dementia 
staging, global cognition, memory, memory and visual abilities, working memory and 
attention, verbal learning and memory, recall, language, premorbid intelligence, literacy/
cognitive reserve, visuospatial, attention, problem-solving, problem solving and perception, 
functional assessment, and daily functioning. Table 1 displays the results of this study in the 
order in which they appear in the text.
Dementia Staging: Clinical Dementia Rating (CDR) Scale
The CDR (Morris, 1993) is a scale that assesses global staging in the development and 
severity of dementia (Juva et al., 1995). The CDR Sum of boxes (CDRsb) demonstrated 
71% sensitivity and 81% specificity (cut-off score of 2.5 or higher) in distinguishing 
dementia, 74% sensitivity and 81% specificity (cut-off score of 2.5 or higher) in 
distinguishing probable Alzheimer’s disease (AD), and 80% sensitivity and 69% specificity 
(cut-off score of 2.0 or higher) in distinguishing possible AD in a sample extracted from the 
2008 National Alzheimer’s Coordinating Center (NACC) uniform data set (O’Bryant et al., 
2010). The CDR has been shown to be able to distinguish between participants with AD and 
controls when comparing English speakers and Spanish speakers. Even in the presence of 
education, age, and cultural differences, the CDR performed as intended in similar cohorts 
(Sano et al., 1997). Although a thorough review of the literature did not yield Spanish 
language CDR sensitivity or specificity, it should be noted that a linguistically adapted CDR 
instrument was developed in 2010 for Puerto Rican populations (Oquendo-Jiménez, Mena, 
Antoun, & Wojna, 2010).
Global Cognition: Alzheimer’s Disease Assessment Scale Cognitive Subscale (ADAS-Cog)
The ADAS-Cog is one of the most widely utilized cognitive assessment tools, measuring 
memory, language, praxis, attention, and cognition (Kolibas, Korinkova, Novotny, 
Vajdickova, & Hunakova, 2000). This tool was originally designed to detect mild cognitive 
impairment and mild to moderate AD (Podhorna, Krahnke, Shear, & Harrison, 2016). It has 
been reported that the ADAS-Cog is limited in its ability to accurately measure progression 
of cognitive impairment when the original scoring protocols are used in comparison with a 













newer scoring method based on a revised factor analysis (Benge, Balsis, Geraci, Massman, 
& Doody, 2009). In addition, researchers found that four items have measurement bias, 
which has resulted in substantial differences in the answers between men and women 
(Verma et al., 2015). Another study found that the items on the ADAs-Cog were usually too 
easy for participants, and this created a very large ceiling affect (50%; Cano et al., 2010). 
This test is widely used in patient settings and clinical trials (Hobart et al., 2013), but has 
many variations in scoring and protocols for administration (Connor & Sabbagh, 2008). This 
prompted the revision and expansion of the ADAS-Cog to the development of the 
Alzheimer’s disease Assessment Scale-Cognitive-Plus (ADAS-CogPlus; Skinner et al., 
2012), which was created to improve responsiveness for MCI measurement and added 
functional ability and executive function domains. However, a thorough review of the 
literature did not yield ADAS-Cog-Plus sensitivity or specificity data. The ADAS-cog (cut-
off score of 10) yielded 78% sensitivity and 100% specificity in a sample of 75 older adults 
(45 MCI vs. 30 controls; Perneczky et al., 2006). The Spanish version of this assessment 
scale (cut-off score of 10) yielded 95.5% sensitivity and 72.94% specificity in distinguishing 
AD in a study of 451 (254 controls, 86 with MCI, and 111 with AD) individuals in Spain 
(Monllau et al., 2007). The adjusted Spanish version of the ADAS-cog for age and schooling 
with the cut-off score of 12 yielded 89.19% sensitivity and 88.53% specificity (Monllau et 
al., 2007). Some challenges for Hispanic populations on this measure may include the 
culturally biased items. For example, items used in the word recall and naming subtests may 
be less salient for some Hispanic cultures due to less exposure to those specific words and 
items.
Memory
The Fuld Object Memory Test (FOME or Fuld).—The FOME or Fuld Test 
(Loewenstein, Duara, Argüelles, & Argüelles, 1995) has been validated as a culture-fair 
method to assess impairment of episodic memory. Objects included in this test were selected 
on the basis of minimizing cultural bias. This measure has specifically shown high cultural 
validity in MCI and later stages of AD (Loewenstein et al., 1995). In a multilanguage study, 
the FOME (cut-off score of 29 or less) yielded 95.9% sensitivity and 100% specificity for 
Spanish speakers (AD = 27 vs. controls = 23) and 95.5% sensitivity and 96.7% specificity in 
English-speaking patients (AD = 111 vs. controls = 30; Loewenstein et al., 1995). The 
FOME (cut-off score of 30) yielded 93.2% sensitivity and 63.5% specificity in a study 
among 140 outpatients (88 with dementia and 52 controls) from the Detroit satellite of the 
Michigan Alzheimer’s disease Research Center (MADRC; Mast, Fitzgerald, Steinberg, 
MacNeill, & Lichtenberg, 2001).
The Short-Term Visual Memory Binding Test.—The Visual Memory Binding Test 
(previously referred to as the Memory Capacity Test) examines short-term memory (STM) 
by asking participants to remember objects, colors, or the colors of objects. After trying to 
integrate these items into their memory, the participants are asked to recall the items, colors, 
or colors of items verbally. Participants with AD perform worse when asked to recall 
objects, and the objects and their respective colors, though their performance was 
significantly impaired when asked to remember objects and colors together (Parra et al., 
2009). Recently this test has been shown to differentiate individuals with amnestic mild 













cognitive impairment and dementia from those who are cognitively normal (Mowrey et al., 
2017). A recent investigation by Buschke et al. (2017) used a Total Number of Items 
recalled in the Paired condition (TIP) score of ≤22 for distinguishing amnestic MCI from 
controls (sensitivity = 0.74, specificity = 0.73) and amnestic MCI and dementia combined 
from controls (sensitivity = 0.84, specificity = 0.73) among 297 older adults (20 with 
dementia, 31 with amnestic MCI, and 246 controls). A 2017 study, which was a substudy of 
the community-based Einstein Aging Study, used a TIP score of ≤17 to distinguish dementia 
from amnestic MCI and controls (sensitivity = 0.95, specificity = 0.87). Although important 
for other tests, age and education adjustments did not have a significant effect in improving 
validity (Buschke et al., 2017). The Memory Binding Test (MBT) has been developed in 
Spanish and Catalan, and those two versions are considered equivalent (Gramunt et al., 
2016), though the Spanish version was found to be affected by factors such as age, 
education, and sex (Gramunt et al., 2015). An Argentine version of the MBT has also been 
developed with words specific to that semantic context, and has shown high sensitivity 
(69%) and high specificity (88%) among a sample of 88 (46 controls and 42 with amnestic 
MCI) monolingual Rioplatense-Spanish speakers for detecting MCI (Roman et al., 2016).
Loewenstein-Acevedo Scales for Semantic Interference and Learning (LASSI-
L).—The LASSI-L (Crocco, Curiel, Acevedo, Czaja, & Loewenstein, 2014) is a recently 
developed scale for the measure of cued recall that allows for the discernment of proactive 
and retroactive interference effects when global memory impairment is a control (Crocco et 
al., 2014). This test has yielded 87.9% sensitivity (when results of the first and second 
semantically related lists of word entered to the model) and 89.4% (when results of the first 
semantically related lists of word entered to the model) to 91.5% (when results of the second 
semantically related lists of word entered to the model) specificity in distinguishing between 
amnestic MCI and controls among a sample of 121 (47 normal, 34 with amnestic MCI, and 
40 with probable AD) older adults. Primary language of the 70.8% of the normal subjects 
was English, and this percentage was 67.6% among older adults with amnestic MCI (Crocco 
et al., 2014). A recent study by Loewenstein and colleagues (Loewenstein et al., 2016) 
measured degrees of cognitive impairment in 93 participants utilizing the LASSI-L (the 
LASSI with an included learning assessment). The results of this study yielded deficits of 
89% for those with MCI and 13% for individuals without impaired cognition. Additionally, 
this test was able to discern subtle differences in cognition to recognize deficits of 47% for 
this who were pre-MCI and 33% for individuals with subjective memory impairment 
(Loewenstein et al., 2016).
This sensitivity in recognizing subtle cognitive impairments through the LASSI-L, along 
with identifying increased amyloid load among neuropsychologically normal community-
dwelling older adults, is a distinguishing characteristic of this assessment in relation to other 
comparable available tests (Loewenstein et al., 2015, 2016). Failure to recover from 
semantic interference (frPSI) has also been found to be related to related to volumetric loss 
or loss of cortical thickness in persons with MCI (Loewenstein et al., 2016, 2017).
More recently, the LASSI-L has been validated in Spanish-speaking populations, yielding an 
area under the curve for discriminating between healthy controls and aMCI equal to 0.909, 
and between healthy controls and mild AD equal to 0.98 (Matías-Guiu et al., 2017). This 













assessment tool yielded a sensitivity of 81.8%, 90.1%, and 75.7% (for cued recalls using list 
A and B of words, and delayed recall respectively) and specificity of 81.6%, 64.7%, and 
92.9% (for cued recalls using list A and B of words, and delayed recall respectively) in 
distinguishing between participants with aMCI and healthy controls (Matías-Guiu et al., 
2017). Utilizing frPSI semantic intrusions, the test is able to distinguish between middle-
aged Spanish-speaking offspring of late onset AD patients and controls as well as different 
patterns of functional connectivity on fMRI. The Spanish versions include items that have 
minimal cultural bias, making it a stronger measure of semantic interference among 
Spanish-speaking populations.
Memory and Visuospatial Abilities: Brief Visuospatial Memory Test—Revised (BVMT-R)
The BVMT-R is an assessment tool that measures delayed recall and delayed yes/no 
recognition task (Benedict, Schretlen, Groninger, Dobraski, & Shpritz, 1996). The final trial 
of the BVMT-R may be particularly challenging for test-takers in cultures in which exposure 
to recognition tasks was minimal in the country where their primary and secondary 
education was obtained. This test is delivered in three trials, in which the respondent studies 
the stimulus page for 10 seconds and is asked to draw as many of the figures viewed as 
possible in their correct location on a page in the response booklet. After a 25-min timed 
hiatus, a delayed recall trial begins, in which the participant is asked to repeat the first task. 
In the third and final trial, the participant is asked to view figures and identify which were 
among the 12 figures that were included in the original trial. If desired, a fourth trial can be 
administered which involves copying the geometric figures. This can be used to screen for 
severe visuo-constructive deficits. The BVMT-R has yielded a sensitivity of 98% and a 
specificity of 82% in distinguishing older adults with dementia (n = 45) from controls (n = 
59; Benedict et al., 1996). Moreover, this test (cut-off score of 17) yielded a sensitivity of 
95% and specificity of 93% in distinguishing normal cognitive performance among a sample 
of 515 adults in the United States (Beier et al., 2017). A thorough review of the literature did 
not reveal Spanish language sensitivity and specificity data. However, Cherner and 
colleagues (2007) utilized this test with monolingual Spanish-speaking Mexican individuals 
and yielded preliminary data regarding further adaption recommendations. This included an 
accounting for years of education that yielded significant improvement in test findings as 
well considering the impact of acculturation on future test outcomes (Cherner et al., 2007).
Working Memory and Attention
Wechsler Memory Scale Fourth Edition (WMS-IV).—The WMS-IV (Pearson, 2009) 
is a widely used working memory scale. The current revised WMS consists of seven subtests 
to measure across memory indexes (Pearson, 2009). The Symbol Span subtest of the WMS-
IV (cut-off score of 14) yielded sensitivity of 50% and specificity of 83% detection of Poor 
Effort among a sample of 143 patients (Young, Caron, Baughman, & Sawyer, 2012). 
Additionally, immediate memory versus delayed memory indexes were determined to yield 
96% sensitivity and 87% specificity in determining multiple sclerosis patients versus 
controls in a sample of 40 (20 with relapsing-remitting multiple sclerosis patients and 20 
controls) patients (Spedo, 2014). The WMS-IV and the third edition (WMS-III) of this tool 
are available in Spanish and commonly utilized in clinical settings. The WMS-III had a 
sensitivity of 71% and 89% in identifying Immediate and Delayed Memory Dysfunction 













respectively among patients with AD (Wechsler, 2004). In a study by Demsky and 
colleagues (1998) among 50 normal Hispanic Americans, using translated version of the 
WMS Revised resulted in a score with an average of one standard deviation lower than 
average. Therefore, it was suggested that clinicians should not use the translated version of 
the English language test without norming and validity testing (Demsky et al., 1998).
Wechsler Adult Intelligence Scale (WAISIV)-Digit Span and Letter Number 
Sequencing Tests.—The subtests Digit Span forward and backward, as well as letter 
number sequencing from the Wechsler Adult Intelligence Scale, fourth edition (WAIS-IV), 
are often used as screening measures for working memory performance. The Digit Span 
subtest of the WAIS, Revised was validated and with a cutting score of eight yielded a 
specificity of 100% and a sensitivity of 27% (Inman & Berry, 2002). Moreover, the Reliable 
Digit Span derived from the Digit Span subtest of the WAIS, with a cutting score of seven, 
yielded a specificity of 82% and a sensitivity of 39% among a sample of 138 veterans 
recruited in a traumatic brain injury clinic (Spencer et al., 2013). There have been Spanish 
language Digit Span adaptations for Mexican, Central American, and Puerto Rican 
populations, which reportedly yielded no major differences in Forward or Backward test 
results (Mejia, Hernandez, Lindsey, Daughtry, & Puente, 2014). Of note, the Spanish 
versions of Wechsler tests are reportedly difficult to obtain in the United States and there 
may be limits on the ability to market and purchase in the U.S. (Ferraro, 2015).
Verbal Learning and Memory
Verbal learning and memory tests are commonly used in clinical setting as a screening tool 
for MCI and dementia. These measures generally contain word lists that belong to certain 
categories (i.e., fruits, vegetables, or means of transportation). The list is presented over 
several trials to give the examinee an opportunity for learning. There is generally an 
immediate and delayed recall trial, as well as a recognition trial. Possible cultural factors 
that may interfere with optimal performance on these tests include the presence of culturally 
biased words, and an unfamiliarity among Hispanic patients with recognition trials.
Hopkins Verbal Learning Test – Revised (HVLT-R)
The HVLT-R is designed to test (Hogervorst et al., 2002) memory and is advantageous to the 
MMSE in that it has no ceiling effect nor education bias. This test has demonstrated 87% 
sensitivity and 98% specificity when assessing for dementia (cut-off score of 14.5) and 91% 
sensitivity and 98% specificity when assessing for AD (cut-off score of 24.5) in a sample of 
82 demented patients and 114 controls as part of the Oxford Project To Investigate Memory 
and Ageing (OPTIMA; Hogervorst et al., 2002). A Spanish language HVLT-R assessment 
(in delay recall score <4) yielded 88% sensitivity and 70% specificity for amnestic MCI and 
96% sensitivity and 85% specificity for AD (cutting point <13) in a sample of 298 older 
adults (54 with AD, 132 amnestic MCI, and 109 controls) recruited in community centers 
and a memory clinic in Spain (Gonzalez-Palau et al., 2013).
Recall: The Rey Auditory Verbal Learning Test (RAVLT)
The RAVLT (Schmidt, 1996) is a widely used assessment for short-term memory and 
learning measurement (Britt, Adams, Godding, Grothues, & Varnado, 1995). The RAVLT 













has demonstrated 75.7% sensitivity and 91.5% specificity in measuring true recognition, 
implicit memory, and automatic memory whereas true and primary memory recognition 
were associated with 73.8% sensitivity and 90% specificity in identifying noncredible 
memory performance in a sample of 174 (61 noncredible, 88 clinic patients, 25 controls) 
fluent English speakers (Boone, Lu, & Wen, 2005). A Spanish language study yielded a total 
score sensitivity of 65% and a specificity of 76% for immediate and delayed recall in a 
sample of 106 Hispanic adults in Puerto Rico (Neblina, 2012).
Language
Boston Naming Test (BNT).—The BNT (Kaplan, Goodglass, Weintraub, & Goodglass, 
1983) is an assessment that tests for recalled naming ability in response to visual stimuli. 
Some cultural factors that may interfere in this test are the presentation of items that are not 
easily translated to Spanish or are culturally biased. The test has been found to be sensitive 
to performance changes along repetitive testing as well as unbiased by practice effects (Huff, 
Collins, Corkin, & Rosen, 1986). In a 2015 study, the BNT demonstrated 57% sensitivity 
and 59% specificity in predicting left seizure focus among a sample of patients with 
temporal-lobe epilepsy (Umfleet et al., 2015). However, two Spanish studies have identified 
39% sensitivity and 89% specificity for detecting AD in a sample of 59 (23 with AD and 36 
controls; Fernández & Fulbright, 2015) and 85% sensitivity and 94% specificity when 
assessing Spanish speakers with AD using the shortened BNT in a sample of 246 
participants (103 with probable AD and 143 controls; Serrano et al., 2001).
Craft Story 21 Recall Immediate/Delayed.—The Craft Story 21 Recall Immediate is a 
test which consists of reading a short story to the participant, who is then asked to recall it 
from memory immediately and tell the interviewer. The primary measure of performance is 
the number of story units recalled and is scored in either a verbatim format or a paraphrased 
format. The delayed format requires the participant to tell the story to the interviewer later 
on in the interview and tests episodic memory. These assessments were utilized in a 
landmark study that demonstrated the impact of plasma insulin levels on patients’ memory. 
This study determined that raising the level of insulin within the body helped to keep levels 
of plasma glucose lowered, therefore promoting memory enhancement within patients (Craft 
et al., 1996). The Craft Story 21 recall, both immediate and delayed, was utilized to measure 
the efficacy of this insulin treatment. Although sensitivity and specificity were not directly 
reported within this study, this assessment has significance in examining how insulin can 
impact memory functioning. Craft Story 21 was recommended to replace Logical Memory, 
Immediate and Delayed in the data collection battery for the National Alzheimer’s 
Coordinating Center (NACC). Spearman’s correlation coefficients were calculated between 
the pairs showing r = .073 between logical memory IA (immediate) and Craft Story 21 
immediate (paraphrase), and r = .77 between logical memory IIA and Craft Story 21 delayed 
(paraphrase). The NACC study showed that both logical memory and Craft Story 21 had the 
lowest accuracy in prediction out of the tests examined in the neuropsychological battery 
(Monsell et al., 2016).
Controlled Oral Word Association Test (COWAT).—The COWAT (Borkowski, 
Benton, & Spreen, 1967) measures letter and category fluency in patients with MCI but is 













not sensitive enough to distinguish healthy controls from those with single-domain amnestic 
MCI (Malek-Ahmadi, Small, & Raj, 2011). This test (cut-off score 5) has yielded a 
sensitivity of 67% and specificity of 88% for detecting malingered neurocognitive 
dysfunction in a sample of 101 (46 presenting malingered neurocognitive dysfunction 
[MND] and 55 without MND) participants (Johnson, Silverberg, Millis, & Hanks, 2012). 
Moreover, this test showed sensitivity of 58% and specificity of 92% in a sample of 26 
adults with Attention Deficit Hyperactivity Disorder (ADHD) and 26 controls (Lovejoy, 
1998), and with the cut of score of 19, sensitivity of 36.5% and specificity of 89.3% among 
sample of. 969 veterans (Sugarman & Axelrod, 2015). A thorough review of the literature 
did not yield any Spanish language data regarding sensitivity or specificity of the COWAT. 
Cherner et al. (2008) administered the COWAT in Spanish (P-M-R) and English (F-A-S) and 
found no significant differences between the two groups.
Multilingual Naming Test (MiNT).—The MiNT is an assessment tool that is designed 
for use with bilingual patients. The purpose of the MiNT is to assess picture naming skills 
for the detection of naming impairments in patients with MCI and AD (Ivanova, Salmon, & 
Gollan, 2013). Items and administration procedures were designed to minimize cultural bias. 
Although this test has been carefully designed for assessment in different languages (i.e., 
English, Spanish, Chinese, and Hebrew), normative data and data on the validity of this test 
are scarce (Fernández, 2013). This test demonstrated positive results for bilingual 
assessment in patients with MCI and AD, with a sensitivity range of 80% to 88% in 
bilinguals, in a sample of 130 (68 with probable AD, 18 with amnestic MCI, and 44 
controls) monolingual English speakers and 29 (18 with probable AD and 11 controls) 
Spanish–English bilinguals (Ivanova et al., 2013). The Multilingual Naming Test was 
recommended to replace the Boston Naming Test in the data collection battery for the 
National Alzheimer’s Coordinating Center. Spearman’s correlation coefficients were 
calculated between the pairs showing r = .076 (Monsell et al., 2016).
Premorbid Intelligence: Nelson Adult Reading Test—American English Version (AMNART)
The AMNART (Grober & Sliwinsk, 1991) is an English-language standardized education-
based assessment that estimates verbal intellectual ability, premorbid intelligence and overall 
cognitive functioning (Lowe & Rogers, 2011). The AMNART has demonstrated 83% 
sensitivity and 81% specificity in dementia differentiation (Vanderploeg, 2014).
Literacy/Cognitive Reserve
Wide-Range Achievement Test-3rd (WRAT-3).—The Wide-Range Achievement Test 
is a test for English speakers. It contains three subtests: reading, spelling, and mathematics 
computation. The reading subtest is used to determine both literacy and cognitive reserve. A 
thorough review of the literature yielded a 46.2% (reading grade-level) and 55.8% (self-
reported education) sensitivity and 84.1% (reading grade-level) and 77.3% (self-reported 
education) specificity for WRAT-3 in combined non-Hispanic White (n = 51) and non-
Hispanic African American (n = 62) English-speaking adults (Rohit et al., 2007). Among 
non-Hispanic White participants, correction based on years of education yielded a higher 
sensitivity and specificity (Rohit et al., 2007). Among African Americans, correction based 
on reading scores yielded in greater specificity compared to correction derived from years of 













education (84.1% and 77.3% respectively; Rohit et al., 2007). Further, the WRAT-3 showed 
a diagnostic accuracy when measuring neurological impairment of African Americans with 
48.4% sensitivity and 77.8% specificity, and 42.9% (47.6: when grade attainment was used 
as a correction factor) sensitivity and 88.5% (92.3: when grade attainment was used as a 
correction factor) specificity for White non-Hispanic participants (Rohit et al., 2007).
The fourth edition of the Wide-Range Achievement Test was published in 2006 (WRAT-4). 
Changes to this version include the addition of a sentence comprehension subtest, as an 
entirely new measure of reading achievement. Additionally, the age-based norms are 
extended from age 75 to 94. The reading subtest has been extended from 42 to 55 items and 
contains new words selected from the EDL Core Vocabularies in reading, mathematics, 
science, and social science. This was done to ensure that a sampling of new words was 
obtained from various grade levels (Wilkinson & Robertson, 2014). A thorough literature 
search revealed no studies examining sensitivity and specificity for dementia groups using 
this version of the test, nor Spanish language versions.
Word Accentuation Test (WAT).—The WAT measures premorbid intelligence of 
Spanish speaking patients through an assessment of the accentuation of infrequently used 
Spanish words that are written without accentuation denotation (Del Ser et al., 1997). This 
test has yielded a 78% sensitivity and 82% specificity in assessing for MCI (Del Ser et al., 
1997).
Visuospatial
Rey–Osterrieth Complex Figure (ROCF)
The ROCF is a widely used assessment tool that evaluates visuospatial construction ability, 
visual memory, visual-motor integration skills (Davies, Field, Andersen, & Pestell, 2011), 
and nonverbal memory (Frank & Landeira-Fernandez, 2008). This test yields 80% 
sensitivity and 90% specificity in measuring neurocognitive response bias (cut-off of ≤50) in 
a sample of 146 credible and 157 noncredible patients (Reedy et al., 2013). Additionally, in 
a study where participants were older adult Spanish-speakers from Spain, the ROCF 
demonstrated 85.7% sensitivity and 98.3% specificity in long delay cued recall and 70% 
sensitivity and 62% specificity for the execution time of Rey Figure in predicting conversion 
to dementia after an MCI diagnosis (García-Herranz, Díaz-Mardomingo, & Peraita, 2016). 
This last factor has a timing component which may interfere with performance among 
cultural groups who have not been previously exposed to this type of testing.
Attention
Stroop Color and Word Test (SCWT).—The SCWT (Golden, 1978) is a measure of 
executive functioning. It is shown to be sensitive to measuring cognitive dysfunction and is a 
tool to measure a patient’s ability to identify the color of a printed word while ignoring the 
content of the written word itself (Mackin, Ayalon, Feliciano, & Areán, 2010). An age and 
education corrected scaled score of this test has yielded an 88% sensitivity and 36.8% 
specificity (cutoff score of 7) in a sample of 52 older adults recruited at a community mental 
health agency in San Francisco (Mackin et al., 2010). Moreover, this test showed 59.2% 













sensitivity and 57.8% specificity with the cutoff score of 5 (Mackin et al., 2010). Evidence 
was located to determine that in a monolingual/bilingual English and Spanish (40 English 
monolinguals, 11 Spanish monolinguals, and 71 Spanish–English bilinguals) study in South 
Florida, bilinguals had a slower response time to the SCWT than their monolingual 
counterparts (Rosselli et al., 2002). However, a 2014 study of adult native Spanish bilingual 
individuals from the United States–Mexico border region yielded findings of a faster 
response time to the Golden version of the Stroop test and subsequent inhibitory control 
advantage for those respondents with greater bilingual proficiency (Suarez et al., 2014). 
Using this test among 200 Spanish-speakers (100 diagnosed with ADHD and 100 controls) 
to distinguish ADHD demonstrated 81% sensitivity and 72% specificity (LópezVillalobos et 
al., 2010).
Trail Making Test.—The Trail Making Test A and B (TMT-A & TMT-B; Reitan, 1958) 
are measures of a patient’s sequencing, psychomotor, visuomotor speed, spatial tracking, 
cognitive flexibility, and set shifting ability. Note that set shifting ability is a part of 
executive functioning that allows a person to switch from one area of concentration to 
another (Ravizza & Carter, 2008). Cultural factors that may interfere with performance on 
this measure among Hispanic individuals is the timing component, which may be affected 
by cultural differences in test-taking attitudes toward speedy completion of the measure. The 
TMT-A is reported to yield a 72% sensitivity and 82% specificity for suboptimal effort in a 
sample of 76 (58 with optimal effort and 18 with suboptimal effort) brain injury patients 
(Powell, Locke, Smigielski, & McCrea, 2011). Further studies have indicated 48% 
sensitivity and 85% specificity for TMT-A & B in a sample of 413 adults (Busse & 
Whiteside, 2012). Additionally, a study measuring traumatic brain injury (causing cognitive 
impairment) indicated between 87% and 100% specificity for TMT-A in a sample of (n = 42 
suspected malingerers and n = 77 genuine) patients with very mild head injury (Iverson, 
Lange, Green, & Franzen, 2002). The TMT-A yielded sensitivity of 24.0% and specificity of 
88.0% among monolingual Spanish-speaking Hispanic participants of a study among people 
living with HIV in distinguishing HIV-Associated Neurocognitive Disorders (Seay, 2015). 
Performance on the TMT yields two scores: times to completion (in seconds) for Parts A 
and B. Additionally, derived scores (i.e., difference B – A, and ratio B:A) are oftentimes 
used in clinical practice to remove the speed component from the test performance, provide 
a more pure measure of executive control, and serve as a possible symptom validity indicator 
(Arango-Lasprilla et al., 2015).
Problem-Solving: Trail Making Test B (TMT-B)
The TMT-B yielded a 50% sensitivity and 80.3% specificity for suboptimal effort in a 
sample of 76 brain injury patients (Powell et al., 2011). This test has demonstrated 69.0% 
sensitivity and 66.9% specificity in detecting mild cognitive impairment, 80.7% sensitivity 
and 31% specificity in detecting AD, and 71.6% sensitivity and 66.9% specificity in 
measuring for both mild cognitive impairment and AD (Ashendorf et al., 2008). A survey of 
475 neuropsychologists in the United States found that the TMT-B is one of the 10 most 
often utilized tests with bilingual and monolingual Hispanic participants in the United States 
(Echemendia & Harris, 2004). A 2011 study determined that, for native Spanish speakers, 
versions of the TMT-B that utilized “Ch” and “D” sounds produced comparable and 













equivalent results (Cherner et al., 2008). The TMT-B yielded sensitivity of 60.0% and 
specificity of 64.0% among monolingual Spanish-speaking Hispanic participants of a study 
among people living with HIV (Seay, 2015).
Problem-Solving and Perception: Clock Face Drawing
The Clock Face Drawing Test (Tuokko, Hadjistavropoulos, Miller, & Beattie, 1992) is an 
assessment that seeks to measure a patient’s frontal and temporal-parietal functioning. The 
Clock Face Drawing Test has been studied extensively, though the Clock Test, which uses a 
predrawn clock, is commonly used in older adult populations. A clock drawing type test is 
included in the Mini-Cog, MMSE, and MOCA assessments. This assessment has yielded a 
sensitivity of 86% and specificity of 92% in classifying older adults with AD versus controls 
(Agrell & Dehlin, 1998). Similar sensitivity rates with specificity of 96% were also reported 
for this test (Burns, Lawlor, & Craig, 2002). The ability to accurately detect an issue in 
cognition varied by level of impairment but not by patient status; classifying 78% of older 
adults with normal cognition, 89% with a mixed dementia type, and 77% of individuals with 
Ad (Manos & Wu, 1994). Among 31 patients with AD and 31 controls in Peru the Spanish 
version of the test using a cut-off score of 6 demonstrated 83.9% sensitivity and 93.5% 
specificity (Oscanoa, 2004).
Functional Assessment
Functional Activities Questionnaire (FAQ).—The FAQ (Pfeffer, Kurosaki, Harrah, 
Chance, & Filos, 1982) measures social functioning and activities of daily living, and mild 
cognitive impairment (Teng et al., 2010). This tool is useful to monitor the changes of 
functioning in activities of daily living that require higher cognitive ability (Mayo, 2016). 
The FAQ yielded 80% sensitivity and 87% specificity for distinguishing mild cognitive 
impairment and very mild AD progression in a sample of 1,801 individuals from the NACC 
dataset (1,108 with MCI and 693 with AD; Teng et al., 2010). Further, there were reported 
85% sensitivity in identifying functional impairment (Mayo, 2016). Cultural factors that 
may affect scores on this measure include differences in social/cultural habits, family 
structure, and lifestyle. However, a 2010 study of 691 individuals indicated no differences in 
sensitivity and specificity outcomes between non-Hispanic and Hispanic participants 
(Tappen et al., 2010). A Spanish language validation yielded 71% (for illiterate participants) 
and 36% (for participants with 1–4 and 5–9 years of education) sensitivity and 79% (for 
illiterate participants), 89% (for participants with 1–4 years of education), and 98% (for 
participants with 5–9 years of education) specificity across education levels in 3,934 older 
adults (55 with mild to moderate dementia, 74 mild MCI, 185 controls) in Mexico City 
(Mejia, Gutiérrez, Villa, & Ostrosky-Solís, 2004).
Blessed Dementia Rating Scale (BDRS).—The BDRS provides informant-based data 
from a simple daily functional scale. It is advantageous in that it allows for long-term 
evaluation, of which the MMSE is unable to perform (Brickman et al., 2002). The BDRS 
comes in both full and modified form, where the full test assesses for everyday activities, 
habits, personality, interest, and drive, whereas the modified version simply tests for 
everyday activities and habits (Park, Jung, & Lim, 1995). The BDRS yielded 96% sensitivity 
and 82% specificity in distinguishing subjects with dementia among a sample of 291 older 













adults (Heun, Papassotiropoulos, & Jennssen, 1998). These activities and habits may 
significantly differ between Hispanic and non-Hispanic cultures. The BDRSTotal (cut-off 
score of 3.5) demonstrated 87% sensitivity and 90% specificity whereas the BDRS-Mod 
(cut-off score of 1.5 for sum of changes in everyday activities and changes in habits) 
demonstrated 90% sensitivity and 89% specificity for detection of AD in a sample of 451 
(86 with MCI, 111 with AD, 254 controls) Spanish-speakers (Peña-Casanova et al., 2005). A 
thorough review of the literature did not yield any additional language data regarding 
sensitivity and specificity. A comparable scale to the BDRS but with information on a 
Spanish version is the Bayer Activities of Daily Living scale (B-ADL), which is a functional 
scale used for those with mild cognitive impairment and mild AD. The B-ADL 
demonstrated 81% sensitivity and 72% specificity to detect differences between MCI and 
AD, and correlates well with the Blessed Dementia Rating Scale (r = .7; Sánchez-Benavides 
et al., 2009).
The Direct Assessment of Functional Status Scale (DAFS).—The DAFS 
(Loewenstein et al., 1989) was one of the first performance-based scales for AD and has 
been translated into multiple languages. The DAFS utilizes caregiver reports to determine 
patient dementia progression across five daily living task domains—driving, telling time, 
remembering lists, basic financial tasks, and complex financial tasks (Pereira, Oliveira, 
Diniz, Forlenza, & Yassuda, 2010). A study on the criterion validity of the financial skills 
subscale of the DAFS yielded 75% sensitivity and 96% specificity in classifying those who 
manage their finances independently from those who do not (Barrett et al., 2009). A 
thorough review of the literature did not yield sensitivity and specificity data for Spanish 
studies. However, a landmark Brazilian Portuguese adaption of this scale yielded 80.6% 
sensitivity and 84.4% specificity for discerning MCI and 100% sensitivity and 93.7% 
specificity for discerning AD in the patient sample (N 89; Pereira et al., 2010). The DAFS-
Revised was developed in response to the need to more sensitively measure early signals and 
changes in MCI in what the DAFS was currently not capturing (McDougall, Becker, 
Vaughan, Acee, & Delville, 2010). The DAFS-R demonstrated cross-cultural validity with a 
Brazilian sample of 89 old adults, yielding 100% sensitivity and 93.7% specificity in 
identifying AD and 80.6% sensitivity and 84.4% specificity for mild cognitive impairment 
(Pereira et al., 2010).
Mood/Daily Functioning
Geriatric Depression Scale (GDS).—The GDS (Yesavage et al., 1982) assesses for 
behavioral clinical depression in older adults through self-report (Marc, Raue, & Bruce, 
2008). A review of the literature yielded a sensitivity of 100% and a specificity of 94% in 
the detection of major depression (cut-score of 14) and a sensitivity of 100% and a 
specificity of 91% in major/double depression cut-score of 13) in a sample of 119 patients 
(Low & Hubley, 2007). The experience of depressive symptoms has been noted to differ 
across cultures. For example, Hispanic cultures often times present with more somatic 
symptoms. A study on 192 older adult Spanish speakers in Spain demonstrated 86.7% 
sensitivity and 63.1% specificity to detect depression (Fernández-San Martín et al., 2002).













Center for Epidemiologic Studies Depression Scale (CES-D) Revised.—The 
CES-D Revised (Eaton, Smith, Ybarra, Muntaner, & Tien, 2004) is a widely used self-report 
depression inventory that measures depressive symptomology (Carleton et al., 2013). This 
scale (cut-off point of 16) has demonstrated a sensitivity of 86% and specificity of 90% in 
distinguishing poststroke depression among a sample of 80 stroke patients (Parikh, Eden, 
Price, & Robinson, 1989). Additionally, a study utilizing the Spanish version of the CES-D 
among a sample of 194 participants (70 with major depressive episode, 63 without major 
depression but with clinical diagnosis of other psychiatric disorders, and 61 with no 
evidence of psychiatric disorders) has yielded a sensitivity of 77.1%, specificity of 79.4%, 
and 78.2% of participants correctly classified with major depressive disorder or other 
psychiatric disorders with the cut-off score of 29 (Ruiz-Grosso et al., 2012). For those with 
major depressive disorder or no evidence of any psychiatric disorders, the Spanish scale 
(cut-off score of 24) demonstrated a sensitivity of 91.4%, a specificity of 96.7%, and an 
ability to correctly classify in 93.9% of cases with a major depressive episode (Ruiz-Grosso 
et al., 2012). Further evidence of the efficacy of the CES-D with diverse populations is 
demonstrated in the following. This test demonstrated very high reliability, α = .94, in 
measuring depression with Hispanic women who were exposed to HIV and intimate partner 
violence risk (Mitrani, McCabe, Gonzalez-Guarda, Florom-Smith, & Peragallo, 2013). A 
2011 study of 504 Spanish-speaking women demonstrated CES-D reliability of α = .93 for 
women with low levels of acculturation and .94 for women with high levels of acculturation 
(McCabe, Vermeesch, Hall, Peragallo, & Mitrani, 2011).
Neuropsychiatric Inventory Questionnaire (NPI-Q).—The NPI-Q (Cummings et al., 
1994) is one of the most widely used tools for outcome measures regarding the evaluation of 
behavioral disturbances in patients with dementia (Lai, 2014). This tool has demonstrated a 
sensitivity of 74.1% and a specificity of 79.5% in assessing neuropsychiatric symptoms in a 
sample of 173 patients with stroke or transient ischemic attack (Wong et al., 2014). Further, 
a validation of the Spanish translation of the NPI-Q, known as the NPI (Boada, Cejudo, 
Tàrraga, López, & Kaufer, 2002), has demonstrated success in screening both patient 
symptomology (r = .879) and as well as caregiver distress (r = .92; Boada et al., 2002).
Discussion
In total, 29 instruments were included in this study for evaluation (see Table 1 for results). 
The following post facto domains emerged: dementia staging, global cognition, memory, 
memory and visuospatial abilities, working memory and attention, verbal learning and 
memory, recall, language, premorbid intelligence, literacy/cognitive reserve, visuospatial 
orientation, attention, problem-solving, problem-solving and perception, functional 
assessment, and mood/daily functioning. Important findings emerged within these domains. 
Around half of the domains had assessment tools with data on gold standard outcomes for 
both English- and Spanish-speakers. Among the assessment tools with data on both Spanish-
and English-speakers, only four assessments were found with consistent outcomes above 
80% (FOME or Fuld, HVLT-R, Clock Face Drawing, and BDRS). These assessments were 
in the following domains: memory, verbal learning and memory, problem-solving and 
perception, and functional assessment (see Table 1). The assessment tools for memory, 













visuospatial abilities, and premorbid intelligence also had consistent outcomes exceeding 
80%, but lack data on sensitivity and specificity among Spanish-speakers. The assessment 
tools in dementia staging and global cognition demonstrated global outcomes above 70%, 
but the CDR lacked data on Spanish-speakers. The assessments that incorporated memory 
tests demonstrated a wide range of cross-language outcomes. The FOME or Fuld 
demonstrated the highest outcomes across language with all scores in a range of 95–100%, 
whereas scores as low as 27% were reported for sensitivity of WAIS-IV among English-
speakers. Cross-language outcomes were limited on assessments related to language 
domain, except for the BNT, which demonstrated low sensitivity and specificity. The 
assessment tool under the premorbid intelligence domain was only applicable for English-
speaking populations and demonstrated outcomes above 80%. Cross-language data 
outcomes were not applicable to tools related to literacy domains, and outcomes had a wide 
range. Similarly, outcomes had a wide range for assessment tools under visuospatial, 
attention, problem solving, functional assessment, and mood/daily functioning (see Table 1 
for results).
Most of the reviewed tools with cross-language data had similar range of outcomes (both 
were above 80% or below 80%); however, in 30% of the reviewed assessment tools, the 
sensitivity and specificity of the tools were above the 80% minimum threshold for English-
speakers, and below this rate among Spanish-speakers, although Spanish-language 
sensitivity and specificity data were not readily available or accessible for all the reviewed 
tools in this study. The findings of this study indicate that testing and utilization of some of 
the reviewed instruments with Spanish-speaking individuals might yield lower sensitivity 
and specificity scores than when used with English-speaking participants.
There was minimal explicit differentiation found between MCI and AD diagnosis in 
sensitivity reporting. In fact, the TMT-B and FAQ for English-speakers and LASSI-L and 
ROCF for Spanish-speakers were the only assessments of all differentiated that between 
MCI and AD diagnosis within sensitivity reporting. Further, the TMT-B was the only 
assessment in the battery that acknowledged and reported cross-language differentiation. 
Participant language proved to be a unique finding. Although most assessments engaged 
native English monolingual speakers, few tests differentiated between participants who were 
bilingual English and Spanish speakers and native Spanish monolingual speakers. Further, 
there was no standard reported differentiation in cultural backgrounds within control or 
assessment groups or consideration of Hispanic and non-Hispanic cultural influences.
The difficulty in locating accurate cross-language electronic data proved to be a limitation in 
this study, as there were no preexisting standard guidelines for data location and the research 
team completed continual exhaustive efforts through diverse search terms, databases, and 
search engines to obtain these scores. Despite this difficulty, the work in this paper 
represents one of the few papers, to the research team’s knowledge, that provides a critical 
review of assessment tool gold standard outcomes in one document, which serves to 
decrease the burden of locating the information contained herein in a myriad of publications 
and locations for clinicians and researchers. Within assessment tools, the wording and 
framing of specific questions may contribute to potential bias in gold standard outcomes. 
The question “which language is your dominant language?” can also be viewed as inherently 













flawed given that for many bilinguals one language is dominant in one domain whereas a 
different language is dominant in another domain”(Gollan, Weissberger, Runnqvist, 
Montoya, & Cera, 2012). Additionally, “establishing which language is dominant is to test 
bilinguals in both languages on an objective measure. However, objective measures can be 
biased if they are more difficult in one language than the other. Further complicating 
matters, it is not always clear how to design difficulty-matched measures across different 
language” (Gollan et al., 2012). In addition, though acculturation is an important 
consideration in neuropsychological testing, there is limited validity data for the 
acculturation scales that are available. A full discussion of acculturation measures is outside 
the scope of the current review, however, Wallace et al. (2010) provided an excellent 
overview of the available psychometric data on acculturation scales, noting that oftentimes 
validity was based solely on content validity.
The purpose of this study was to compile and assess a collection of dementia-spectrum 
assessment tools and evaluate the known sensitivity and specificity of these instruments to 
aid in uniform reporting. This study attempted to assess the current availability of 
psychometric data available for neuropsychological instruments, which may be administered 
to Hispanic and white non-Hispanic older adults presenting for evaluation related to memory 
disorders. Reviews of this nature are sparse, and this is one of the few to provide an 
overview of available Spanish-translated neuropsychological instruments and their 
sensitivity and specificity in detecting dementia-spectrum disorders. This review identified a 
need for additional neuropsychological instruments to be made available and normed in 
Spanish to best serve diverse populations, though the development of normative thresholds 
needs to account for the diversity within the Spanish community. Country and ethnicity-
specific testing should be completed to validate an instrument in the precise community 
within which researchers and clinicians intend administer the measurement tool.
This study integrates gold standard neuropsychological assessment outcomes from the past 
50 years (Reitan, 1958) to present. Literature encouraging the investigation of the 
heterogeneity in psychometric properties and outcomes in the wide range of available 
assessments is only recently emerging (Costa et al., 2017). The strength of this study lies 
within the utilization of gold standard criterion for which there can be appropriate 
discernment for efficacy in assessment utilization. This study should serve as an additional 
step in this movement toward standardized psychometric properties and outcome reporting 
in dementia-spectrum assessment within the literature. Recommendations for future cross-
language assessments include the acknowledgment and integration of culturally relevant 
questions within assessments that account for Hispanic cultural, language, and identity 
nuances, as well as the recognition of gold standard criterion as a method for discernment of 
a particular assessment’s performance ability. This study can act as a bridge between 
research and clinical practice where researchers and clinicians can find centralized, uniform 
reporting for appropriate assessment selection and subsequent research engagement and 
clinical service delivery. This review has demonstrated the need for clinicians to consider 
their patients’ unique cultural and language differences when determining which 
neuropsychological assessment to utilize for efficiency and efficacy in service delivery. It is 
recommended that clinicians engaging with culturally diverse populations use sound 













professional discretion and judgment in their clinical practice when selecting and utilizing a 
particular neuropsychological assessment in their practice.
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